Yayın:
Comparative study on the antileishmanial activities of chemically and biologically synthesized silver nanoparticles (AgNPs)

Yükleniyor...
Küçük Resim

Tarih

Kurum Yazarları

Danışman

item.page.editor

Editör

Bölüm / Program

Dergi Başlığı

Dergi ISSN

Cilt Başlığı

Yayıncı

SPRINGER HEIDELBERG

DOI

10.1007/s13205-018-1121-6

Türü

View PlumX Details

Araştırma Projeleri

Akademik Birimler

Dergi Sayısı

Özet

The present study was conducted to investigate the antileishmanial activity of biogenic silver nanoparticles (AgNPs) compared to chemically synthesized AgNPs. A nano dimension size (10-15 nm) biogenic AgNPs was produced and characterized by UV-Vis spectroscopy and X-rays diffraction. The chemically synthesized AgNPs was recovering from our previous study with a nanoparticle (NP) size in the range of 10-40 nm. The antileishmanial activities were investigated through 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide cell viability assay. The infectivity was determined by Giemsa staining of the infected macrophages cells. Nitric oxide (NO) accumulation was measured by Griess reagent using NaNO2 as a positive control. After 24 h of exposure with nanoparticles (NPs), a concentration-dependent growth inhibition was observed. The IC50 values were determined against promastigotes of L. infantum as 19.42 +/- 2.76 mu g/ml for leaves aqueous extract mediated AgNPs, 30.71 +/- 1.91 mu g/ml for stem mediated AgNPs and 51.23 +/- 2.20 mu g/ml for chemically synthesized AgNPs. It was also detected that all types of NPs produced NO at a significant level. However, the production of a high-level of NO in the biologically synthesized NPs activated macrophage cells, infected with L. infantum promastigotes indicates that NO radicals are mainly responsible for induced cell death and a decrease in the pathogenicity of the parasites. Since, biogenic nanoparticles are cost-effective, eco-friendly, simple to synthesize, and more effective than chemically synthesized silver nanoparticles, therefore, it could be used as a potential alternative for the development of antileishmanial drugs.

Tanım

Dergi veya Seri

3 BIOTECH

ISSN

2190-572X

ISBN

Alıntı

Koleksiyonlar

Onay

Gözden geçir

Tamamlayıcı Bilgiler

Referans Gösteren

Related Patent

Related Goal

0

Views

0

Downloads